Ascendis Pharma (ASND) said the FDA has accepted for its supplemental Biologics License Application for TransCon hGH for the treatment of adult growth hormone deficiency, or GHD. The agency has set a ...

The therapies included are once-weekly human growth hormone, SKYTROFA (lonapegsomatropin), along with TransCon CNP ...

Today, the older sister stands 154 cm, while the younger twin is 155 cm — both are still below the median height of 156.3 cm ...

The global hormone replacement therapy market size was US$ 32.1 billion in 2021. The global hormone replacement therapy market is forecast to grow to US$ 51.1 billion by 2030 by growing at a compound ...

In this complete MK-677 guide I’m going to tell you everything you need to know about this potentially potent muscle builder, ...